{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:06:47Z","timestamp":1789164407142,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Drug Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fungal-contaminated compounded pharmaceuticals and medical devices pose a public health problem. This review aimed to provide an organized overview of the literature on that critical issue. Firstly, it was found that compounding pharmacies can produce drugs that are contaminated with fungi, leading to outbreaks of severe fungal diseases. Secondly, inadequate sterile compounding techniques or storage conditions, or exceeding the limit of a fungal count, can result in fungal contamination. Lastly, nanotools can be used to rapidly detect fungi, thus improving fungal diagnostic procedures. To achieve this goal, we have reviewed the published data on PubMed, the CDC, and FDA Web sites, and a literature search was undertaken to identify severe fungal infections associated with compounding pharmacies outside of hospitals, limited by the dates 2003 to 2021. The \u201cPreferred Reporting Items for Critical Reviews\u201d were followed in searching, including, and excluding papers. Fungal outbreaks have been documented due to contaminated pharmaceuticals and medical devices. In 2013, 55 people died from fungal meningitis caused by contaminated steroid injections containing methylprednisolone acetate. Additionally, in 2021, <jats:italic>Aspergillus penicillioides<\/jats:italic> contamination was reported in ChloraPrep drugs, which was attributed to the storage conditions that were conducive to the growth of this fungus. These incidents have resulted in severe infectious diseases, such as invasive mycoses, cornea infections, Endophthalmitis, and intestinal and gastric mycosis. By implementing preventive measures and policies, it is possible to avoid these outbreaks. Creating Nano-diagnostics presents a major challenge, where promptly diagnosing fungal infections is required to determine the proper corrective and preventive measures.<\/jats:p>","DOI":"10.1007\/s00284-023-03506-7","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:01:46Z","timestamp":1700240506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Fungal Diseases Caused by Serious Contamination of Pharmaceuticals and Medical Devices, and Rapid Fungal Detection Using Nano-Diagnostic Tools: A Critical Review"],"prefix":"10.1007","volume":"81","author":[{"given":"Mohamed Abd El-Gawad El-Sayed","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-1641","authenticated-orcid":false,"given":"Heba S.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muddukrishnaiah","family":"Kotakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"3506_CR1","unstructured":"FDA , 2015, Compounding and the FDA: Questions and answers. Available at: http:\/\/www.fda.gov\/Drugs\/ GuidanceComplianceRegulatoryInformation\/PharmacyCompounding\/ucm339764.htm"},{"key":"3506_CR2","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2146\/ajhp130112","volume":"70","author":"CE Myers","year":"2013","unstructured":"Myers CE (2013) History of sterile compounding in US hospitals: learning from the tragic lessons of the past. Am J Health Syst Pharm 70:1414\u20131427. https:\/\/doi.org\/10.2146\/ajhp130112","journal-title":"Am J Health Syst Pharm"},{"key":"3506_CR3","doi-asserted-by":"publisher","unstructured":"Kastango EC, Douglass KH. Clinical IQ LLC. [Accessed Jan 5, 2015] Quality standards for large scale sterile compounding facilities. doi: https:\/\/doi.org\/10.1093\/ajhp\/61.18.1928.","DOI":"10.1093\/ajhp\/61.18.1928"},{"key":"3506_CR4","unstructured":"United States Pharmacopia, Microbiological Tests. In: The United States Pharmacopeia, 30th\u00a0revision and the National Formulary, 25th\u00a0edition (USP-NF). Rockville, Maryland; United States Pharmacopeial Convention, 2007."},{"issue":"3","key":"3506_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsps.2014.11.015","volume":"23","author":"M Ratajczak","year":"2015","unstructured":"Ratajczak M, Kubicka MM, Kami\u0144ska D, Sawicka P, D\u0142ugaszewska J (2015) Microbiological quality of non-sterile pharmaceutical products. Saudi Pharm J 23(3):303\u2013307. https:\/\/doi.org\/10.1016\/j.jsps.2014.11.015","journal-title":"Saudi Pharm J"},{"issue":"1","key":"3506_CR6","first-page":"4","volume":"17","author":"R Vijayakumar","year":"2012","unstructured":"Vijayakumar R, Sandle T, Manoharan C (2012) A review of fungal contamination in pharmaceutical products and phenotypic identification of contaminants by conventional methods. Eur J Parent Pharm Sci 17(1):4\u201319","journal-title":"Eur J Parent Pharm Sci"},{"issue":"1","key":"3506_CR7","first-page":"68","volume":"19","author":"T Sandle","year":"2014","unstructured":"Sandle T (2014) Fungal contamination of pharmaceutical products: the growing menace. Eur Pharm Rev 19(1):68\u201371","journal-title":"Eur Pharm Rev"},{"issue":"3","key":"3506_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/0028-3886.35679","volume":"55","author":"A Chakrabarti","year":"2007","unstructured":"Chakrabarti A (2007) Epidemiology of central nervous system mycoses. Neurol India 55(3):191\u2013197. https:\/\/doi.org\/10.4103\/0028-3886.35679","journal-title":"Neurol India"},{"issue":"3","key":"3506_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-2000-9394","volume":"20","author":"M Gottfredsson","year":"2000","unstructured":"Gottfredsson M, Perfect JR (2000) Fungal meningitis. Semin Neurol 20(3):307\u2013322. https:\/\/doi.org\/10.1055\/s-2000-9394","journal-title":"Semin Neurol"},{"key":"3506_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mmcr.2018.01.004","volume":"20","author":"H Shah","year":"2018","unstructured":"Shah H, Honeybul S, Tang S, Arthur I, McLaren S, Boan P (2018) Mould meningitis associated with intravenous drug use. Med Mycol Case Rep 20:18\u201320. https:\/\/doi.org\/10.1016\/j.mmcr.2018.01.004","journal-title":"Med Mycol Case Rep"},{"issue":"6","key":"3506_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/BF01719297","volume":"10","author":"L Monno","year":"1994","unstructured":"Monno L, Angarano G, Montagna MT, Coppola S, Carbonara S, Bellisario A (1994) Chronic cryptococcal meningitis in an intravenous drug addict without evidence of infection by HIV-1,2 in southern Italy. Eur J Epidemiol 10(6):773\u2013774. https:\/\/doi.org\/10.1007\/BF01719297","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"3506_CR12","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/clinids\/19.6.1133","volume":"19","author":"RJ Hopkins","year":"1994","unstructured":"Hopkins RJ, Rothman M, Fiore A, Goldblum SE (1994) Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis 19(6):1133\u20131137. https:\/\/doi.org\/10.1093\/clinids\/19.6.1133. (PMID: 7888545)","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3506_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","volume":"91","author":"TK Kourkoumpetis","year":"2012","unstructured":"Kourkoumpetis TK, Desalermos A, Muhammed M, Mylonakis E (2012) Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature. Med (Baltimore) 91(6):328\u2013336. https:\/\/doi.org\/10.1097\/MD.0b013e318274cd77","journal-title":"Med (Baltimore)"},{"key":"3506_CR14","unstructured":"FDA,2012, Multistate outbreak of fungal meningitis and other infections. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/multistate-outbreak-fungal-meningitis-and-other-infections"},{"issue":"13","key":"3506_CR15","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/ani12131699","volume":"12","author":"GN Marques","year":"2022","unstructured":"Marques GN, Cota JB, Leal MO, Silva NU, Flanagan CA, Crosta L, Tavares L, Oliveira M (2022) First documentation of exophiala spp. Isolation in psittaciformes. Animals 12(13):1699. https:\/\/doi.org\/10.3390\/ani12131699","journal-title":"Animals"},{"key":"3506_CR16","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3201\/eid2303.161334","volume":"368","author":"RM Smith","year":"2013","unstructured":"Smith RM, Tipple M, Chaudry MN, Schaefer MK, Park BJ (2013) Relapse of fungal meningitis associated with contaminated methylprednisolone. N Engl J Med 368:2535\u20132536. https:\/\/doi.org\/10.3201\/eid2303.161334","journal-title":"N Engl J Med"},{"key":"3506_CR17","unstructured":"FDA 2020 BD Announces Voluntary Recall of ChloraPrep\u2122 3 mL Applicator in Specific US Territories and Countries. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/bd-announces-voluntary-recall-chlorapreptm-3-ml-applicator-specific-us-territories-and-countries"},{"key":"3506_CR18","unstructured":"FDA2021. BD Expands Voluntary Recall of ChloraPrep\u2122 3 mL Applicator Nationwide to Include All US States. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/bd-expands-voluntary-recall-chlorapreptm-3-ml-applicator-nationwide-include-all-us-states"},{"key":"3506_CR19","unstructured":"FDA 2020. MarcasUSA, LLC Issues Voluntary Nationwide Recall of Pasta De Lassar Andromaco Skin Protectant 25% Zinc Oxide 60g Due to Potential Contamination. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/marcasusa-llc-issues-voluntary-nationwide-recall-pasta-de-lassar-andromaco-skin-protectant-25-zinc#recall-announcement"},{"key":"3506_CR20","unstructured":"FDA 2021. Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi\u00ae(amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/jacobus-pharmaceutical-company-inc-issues-voluntary-worldwide-recall-ruzurgir-amifampridine-10-mg"},{"key":"3506_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jama.289.3.291","volume":"51","author":"J Engemann","year":"2002","unstructured":"Engemann J, Kaye K, Cox G, Perfect J, Schell W, McGarry SA, Patterson K, Edupuganti S et al (2002) Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States, July-November 2002. Morb Mortal Wkly Rep 51:1109\u20131112. https:\/\/doi.org\/10.1001\/jama.289.3.291","journal-title":"Morb Mortal Wkly Rep"},{"key":"3506_CR22","first-page":"4","volume":"1305","author":"Anon.","year":"2010","unstructured":"Anon. (2010) IV bags from Claris Lifesciences contaminated. React Wkly 1305:4","journal-title":"React Wkly"},{"key":"3506_CR23","unstructured":"Anon.\u00a0(2013)\u00a0FDA Approved Risk Evaluation and Mitigation Strategies (REMS).\u00a0Bethesda, MD: FDA. Available at:\u00a0http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm214035.htm Accessed Apr 6, 2015."},{"key":"3506_CR24","first-page":"310","volume":"61","author":"Anon.","year":"2012","unstructured":"Anon. (2012) Centers for disease control and prevention (CDC). Notes from the field: multistate outbreak of postprocedural fungal Endophthalmitis associated with a single compounded pharmacy\u2014United States, March\u2013April 2012. MMWR Morb Mortal Wkly Rep 61:310\u2013311","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3506_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3201\/eid2002.131257","volume":"20","author":"CA Mikosz","year":"2014","unstructured":"Mikosz CA, Smith RM, Kim M, Tyson C, Lee EH, Adams E, Straif-Bourgeois S, Rowadsky R et al (2014) Fungal endophthalmitis associated with compounded products. Emerg Infect Dis 20:248\u2013256. https:\/\/doi.org\/10.3201\/eid2002.131257","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"3506_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.ophtha.2013.10.040","volume":"121","author":"KW Small","year":"2014","unstructured":"Small KW, Chan CK, Silva-Garcia R, Walsh TJ (2014) Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Ophthalmology 121(4):952\u2013958. https:\/\/doi.org\/10.1016\/j.ophtha.2013.10.040","journal-title":"Ophthalmology"},{"issue":"5","key":"3506_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamaophthalmol.2014.257","volume":"132","author":"D Minckler","year":"2014","unstructured":"Minckler D, Small KW, Walsh TJ (2014) Clinical and pathologic features of bipolaris endophthalmitis after intravitreal triamcinolone. JAMA Ophthalmol 132(5):630\u2013632. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.257","journal-title":"JAMA Ophthalmol"},{"key":"3506_CR28","unstructured":"Center for disease control and prevention 2012. https:\/\/www.cdc.gov\/fungal\/diseases\/other\/exserohilum-rostratum.html"},{"key":"3506_CR29","unstructured":"FDA 2017. Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Linezolid Injection 600mg\/300ml, Due to Presence White Particulate Matter that has been Identified as Mold. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/auromedics-pharma-llc-issues-voluntary-nationwide-recall-linezolid-injection-600mg300ml-due-presence"},{"key":"3506_CR30","unstructured":"Rockoff, J.D.\u00a0(2013)\u00a0\u201cJohnson & Johnson recalls some vials of antipsychotic treatment\u201d.\u00a0Wall Street J\u00a0Available at:\u00a0http:\/\/www.wsj.com\/articles\/SB10001424127887323864604579069562068648566 Accessed Apr 6, 2015."},{"key":"3506_CR31","unstructured":"FDA 2014 http:\/\/www.fda.gov\/MedicalDevices\/Safety\/, https:\/\/www.medicaldevice-network.com\/news\/newschildrens-medical-ventures-recall-4441294\/"},{"issue":"2","key":"3506_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2217\/fmb.12.138","volume":"8","author":"A Casadevall","year":"2013","unstructured":"Casadevall A, Pirofski LA (2013) Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiol 8(2):135\u2013137. https:\/\/doi.org\/10.2217\/fmb.12.138","journal-title":"Future Microbiol"},{"key":"3506_CR33","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1128\/CMR.00019-10","volume":"23","author":"SG Revankar","year":"2010","unstructured":"Revankar SG, Sutton DA (2010) Melanized fungi in human disease. Clin Microbiol Rev 23:884\u2013928. https:\/\/doi.org\/10.1128\/CMR.00019-10","journal-title":"Clin Microbiol Rev"},{"key":"3506_CR34","doi-asserted-by":"crossref","unstructured":"CDC.\u00a0Fusarium\u00a0keratitis---multiple states, 2006. MMWR 2006;55:400--1.","DOI":"10.5771\/0490-1606-2006-10-400"},{"issue":"23","key":"3506_CR35","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.3390\/jcm10235468","volume":"10","author":"M Szali\u0144ski","year":"2021","unstructured":"Szali\u0144ski M, Zgry\u017aniak A, Rubisz I, Gajdzis M, Kaczmarek R, Prze\u017adziecka-Do\u0142yk J (2021) Fusarium keratitis\u2014review of current treatment possibilities. J Clin Med 10(23):5468. https:\/\/doi.org\/10.3390\/jcm10235468","journal-title":"J Clin Med"},{"key":"3506_CR36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.eye.6700557","volume":"17","author":"PA Thomas","year":"2003","unstructured":"Thomas PA (2003) Fungal infections of the cornea. Eye 17:852\u2013862. https:\/\/doi.org\/10.1038\/sj.eye.6700557","journal-title":"Eye"},{"key":"3506_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00003226-200305000-00004","volume":"22","author":"D Dursun","year":"2003","unstructured":"Dursun D, Fernandez V, Miller D, Alfonso EC (2003) Advanced Fusarium keratitis progressing to Endophthalmitis. Cornea 22:300\u2013303. https:\/\/doi.org\/10.1097\/00003226-200305000-00004","journal-title":"Cornea"},{"issue":"9","key":"3506_CR38","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1128\/JCM.00908-09","volume":"47","author":"VCC Cheng","year":"2009","unstructured":"Cheng VCC, Chan JFW, Ngan AHY, To KKW, Leung SY, Tsoi HW (2009) Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 47(9):2834\u20132843.","journal-title":"J Clin Microbiol"},{"key":"3506_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1023\/A:1008974621698","volume":"16","author":"BZ Han","year":"2000","unstructured":"Han BZ, Nout MJR (2000) Effects of temperature, water activity and gas atmosphere on mycelial growth of tempe fungi Rhizopus microsporus var. microsporus and Rhizopus microsporus var. oligosporus. World J Microbiol & Biotechnol 16:853\u2013858. https:\/\/doi.org\/10.1023\/A:1008974621698","journal-title":"World J Microbiol & Biotechnol"},{"key":"3506_CR40","unstructured":"Rowe, R.C., Sheskey, PJ and Quinn, M.E. (2009) Handbook of Pharmaceutical Excipients. 6th Edition, Pharmaceutical Press, 506\u2013509."},{"key":"3506_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0140-6736(96)05059-3","volume":"348","author":"SJ Mitchell","year":"1996","unstructured":"Mitchell SJ, Gray J, Morgan MEI (1996) Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 348:441\u2013443. https:\/\/doi.org\/10.1016\/s0140-6736(96)05059-3","journal-title":"Lancet"},{"key":"3506_CR42","first-page":"1265","volume":"37","author":"LB Khan","year":"1963","unstructured":"Khan LB (1963) Gastric mucormycosis: report of a case with a review of the literature. S Afr Med J 37:1265\u20131269","journal-title":"S Afr Med J"},{"key":"3506_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00134-003-2132-1","volume":"30","author":"E Marav\u00ed-Poma","year":"2004","unstructured":"Marav\u00ed-Poma E, Rodr\u00edguez-Tudela JL, de Jal\u00f3n JG et al (2004) outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med 30:724\u2013728. https:\/\/doi.org\/10.1007\/s00134-003-2132-1","journal-title":"Intensive Care Med"},{"issue":"3","key":"3506_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/jof5030069","volume":"5","author":"KP Hartnett","year":"2019","unstructured":"Hartnett KP, Jackson BR, Perkins KM, Glowicz J, Kerins JL, Black SR, Lockhart SR, Christensen BE, Beer KD (2019) A guide to investigating suspected outbreaks of mucormycosis in healthcare. J Fungi 5(3):69. https:\/\/doi.org\/10.3390\/jof5030069","journal-title":"J Fungi"},{"key":"3506_CR45","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","volume":"328","author":"PA Pizzo","year":"1993","unstructured":"Pizzo PA (1993) Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med 328:1323\u20131332. https:\/\/doi.org\/10.1056\/NEJM199305063281808","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"3506_CR46","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/clinids\/14.supplement_1.s43","volume":"14","author":"E Anaissie","year":"1992","unstructured":"Anaissie E (1992) Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 14(Suppl 1):S43-53. https:\/\/doi.org\/10.1093\/clinids\/14.supplement_1.s43","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3506_CR47","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/MOP.0000000000000031","volume":"25","author":"F Lanternier","year":"2013","unstructured":"Lanternier F, Cypowyj S, Picard C et al (2013) Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr 25(6):736\u2013747. https:\/\/doi.org\/10.1097\/MOP.0000000000000031","journal-title":"Curr Opin Pediatr"},{"issue":"9","key":"3506_CR48","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-4632.2004.02175.x","volume":"43","author":"VC Hall","year":"2004","unstructured":"Hall VC, Goyal S, Davis MD, Walsh JS (2004) Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol 43(9):648\u2013653. https:\/\/doi.org\/10.1111\/j.1365-4632.2004.02175.x","journal-title":"Int J Dermatol"},{"issue":"10","key":"3506_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.7326\/0003-4819-125-10-199611150-00003","volume":"125","author":"B Orth","year":"1996","unstructured":"Orth B, Frei R, Itin PH, Rinaldi MG, Speck B, Gratwohl A, Widmer AF (1996) Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 125(10):799\u2013806. https:\/\/doi.org\/10.7326\/0003-4819-125-10-199611150-00003","journal-title":"Ann Intern Med"},{"key":"3506_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-5945-6-1","volume":"6","author":"G Kampf","year":"2006","unstructured":"Kampf G, Ennen J (2006) Regular use of a hand cream can attenuate skin dryness and roughness caused by frequent hand washing. BMC Dermatol 6:1. https:\/\/doi.org\/10.1186\/1471-5945-6-1","journal-title":"BMC Dermatol"},{"issue":"7","key":"3506_CR51","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1128\/AAC.42.7.1601","volume":"42","author":"C Aguilar","year":"1998","unstructured":"Aguilar C, Pujol I, Sala J, Guarro J (1998) Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother 42(7):1601\u20131604. https:\/\/doi.org\/10.1128\/AAC.42.7.1601","journal-title":"Antimicrob Agents Chemother"},{"key":"3506_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.survophthal.2010.09.002","volume":"56","author":"N Bhagat","year":"2011","unstructured":"Bhagat N, Nagori S, Zarbin M (2011) Post-traumatic Infectious Endophthalmitis. Surv Ophthalmol 56:214\u2013251. https:\/\/doi.org\/10.1016\/j.survophthal.2010.09.002","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"3506_CR53","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1128\/JCM.01965-12","volume":"50","author":"KC da Cunha","year":"2012","unstructured":"da Cunha KC, Sutton DA, Fothergill AW et al (2012) Diversity of Bipolaris species in clinical samples in the United States and their antifungal susceptibility profiles. J Clin Microbiol 50(12):4061\u20134066. https:\/\/doi.org\/10.1128\/JCM.01965-12","journal-title":"J Clin Microbiol"},{"issue":"7","key":"3506_CR54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaophthalmol.2013.88","volume":"131","author":"AT Sheyman","year":"2013","unstructured":"Sheyman AT, Cohen BZ, Friedman AH, Ackert JM (2013) An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. JAMA Ophthalmol 131(7):864\u2013869. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.88","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"3506_CR55","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s40135-013-0033-1","volume":"31","author":"AA Moshfeghi","year":"2011","unstructured":"Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr et al (2011) Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 31(4):662\u2013668. https:\/\/doi.org\/10.1007\/s40135-013-0033-1","journal-title":"Retina"},{"issue":"4","key":"3506_CR56","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","volume":"31","author":"CA McCannel","year":"2011","unstructured":"McCannel CA (2011) Meta-analysis of Endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31(4):654\u2013661. https:\/\/doi.org\/10.1097\/IAE.0b013e31820a67e4","journal-title":"Retina"},{"key":"3506_CR57","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/cid\/ciq204","volume":"52","author":"J Riddell IV","year":"2011","unstructured":"Riddell J IV, Comer GM, Kauffman CA (2011) Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis 52:648\u2013653. https:\/\/doi.org\/10.1093\/cid\/ciq204","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3506_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/diagnostics12030679","volume":"12","author":"C Danielescu","year":"2022","unstructured":"Danielescu C, Stanca HT, Iorga R-E, Darabus D-M, Potop V (2022) The diagnosis and treatment of fungal endophthalmitis: an update. Diagnostics 12(3):679. https:\/\/doi.org\/10.3390\/diagnostics12030679","journal-title":"Diagnostics"},{"key":"3506_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/15569543.2021.192569","author":"J Yu","year":"2021","unstructured":"Yu J, Yang M, Han J, Pang X (2021) Fungal and mycotoxin occurrence, affecting factors, and prevention in herbal medicines: a review. Toxin Rev. https:\/\/doi.org\/10.1080\/15569543.2021.192569","journal-title":"Toxin Rev"},{"key":"3506_CR60","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2022.030","author":"HS Abbas","year":"2021","unstructured":"Abbas HS, Muddukrishnaiah K (2021) Lectins are the sparkle of hope for combating coronaviruses and the global COVID 19. Adv Pharm Bull. https:\/\/doi.org\/10.34172\/apb.2022.030","journal-title":"Adv Pharm Bull"},{"key":"3506_CR61","first-page":"313","volume-title":"Oxford Textbook of Medical Mycology","author":"PL White","year":"2018","unstructured":"White PL, Barnes RA (2018) Molecular diagnosis of fungal diseases. In: Kibbler CC, Barton RC, Gow NAR, Howell S, MacCallum DM, Manuel R (eds) Oxford Textbook of Medical Mycology. Oxford University Press, Hong Kong, China, pp 313\u2013326"},{"key":"3506_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25129-w","volume":"8","author":"K Wagner","year":"2018","unstructured":"Wagner K, Springer B, Pires VP, Keller PM (2018) Molecular detection of fungal pathogens in clinical specimens by 18S rDNA high-throughput screening in comparison to ITS PCR and culture. Sci Rep 8:1\u20137. https:\/\/doi.org\/10.1038\/s41598-018-25129-w","journal-title":"Sci Rep"},{"key":"3506_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0123-9392(12)70029-2","volume":"16","author":"P Lewis White","year":"2012","unstructured":"Lewis White P, Loeffler J, Barnes RA, Peter Donnelly J (2012) Towards a standard for aspergillus PCR\u2014Requirements, process and results. Infectio 16:64\u201372. https:\/\/doi.org\/10.1016\/S0123-9392(12)70029-2","journal-title":"Infectio"},{"key":"3506_CR64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12281-020-00374-7","volume":"14","author":"PL White","year":"2020","unstructured":"White PL, Alanio A, Cruciani M, Gorton R, Millon L, Rickerts V, Barnes RA, Donnelly JP, Loeffler J (2020) Nucleic acid tools for invasive fungal disease diagnosis. Current Fungal Infection Reports 14:76\u201388. https:\/\/doi.org\/10.1007\/s12281-020-00374-7","journal-title":"Current Fungal Infection Reports"},{"issue":"1","key":"3506_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.17509\/ijost.v4i1.15806","volume":"4","author":"AB Nandiyanto","year":"2019","unstructured":"Nandiyanto AB, Oktiani R, Ragadhita R (2019) How to read and interpret FTIR spectroscope of organic material. Indonesian J Sci Technol 4(1):97\u2013118. https:\/\/doi.org\/10.17509\/ijost.v4i1.15806","journal-title":"Indonesian J Sci Technol"},{"issue":"6","key":"3506_CR66","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/app9061163","volume":"9","author":"M Chisanga","year":"2019","unstructured":"Chisanga M, Muhamadali H, Ellis DI, Goodacre R (2019) Enhancing disease diagnosis: biomedical applications of surface-enhanced Raman scattering. Appl Sci 9(6):1163. https:\/\/doi.org\/10.3390\/app9061163","journal-title":"Appl Sci"},{"key":"3506_CR67","doi-asserted-by":"publisher","unstructured":"Vanhee LM, D\u2019Haese E, Cools I, Nelis HJ, Coenye T. Detection and quantification of bacteria and fungi using solid-phase cytometry. In Detection of Bacteria, Viruses, Parasites and Fungi: Bioterrorism Prevention 2010 (pp. 25\u201341). Springer Netherlands. doi:\u00a0https:\/\/doi.org\/10.1007\/978-90-481-8544-3_2","DOI":"10.1007\/978-90-481-8544-3_2"},{"issue":"5","key":"3506_CR68","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/microorganisms7050130","volume":"7","author":"R Franco-Duarte","year":"2019","unstructured":"Franco-Duarte R, \u010cern\u00e1kov\u00e1 L, Kadam S, Kaushik K, Salehi B, Bevilacqua A, Corbo MR, Antolak H, Dybka-St\u0119pie\u0144 K, Leszczewicz M, Relison Tintino S (2019) Advances in chemical and biological methods to identify microorganisms\u2014from past to present. Microorganisms. 7(5):130. https:\/\/doi.org\/10.3390\/microorganisms7050130","journal-title":"Microorganisms."},{"issue":"2","key":"3506_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/mmy\/myx035","volume":"56","author":"MG Gerritsen","year":"2018","unstructured":"Gerritsen MG, Brinkman P, Escobar N, Bos LD, De Heer K, Meijer M, Janssen HG, De Cock H, W\u00f6sten HA, Visser CE, van Oers MH (2018) Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography\u2013mass spectrometry. Med Mycol 56(2):253\u2013256. https:\/\/doi.org\/10.1093\/mmy\/myx035","journal-title":"Med Mycol"},{"issue":"4","key":"3506_CR70","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/jof6040349","volume":"6","author":"K Hussain","year":"2020","unstructured":"Hussain K, Malavia D, Johnson E, Littlechild J, Winlove CP, Vollmer F, Gow NA (2020) Biosensors and diagnostics for fungal detection. J Fungi 6(4):349. https:\/\/doi.org\/10.3390\/jof6040349","journal-title":"J Fungi"},{"key":"3506_CR71","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijbiomac.2017.12.084","volume":"110","author":"I Bhatnagar","year":"2018","unstructured":"Bhatnagar I, Mahato K, Ealla KKR, Asthana A, Chandra P (2018) Chitosan stabilized gold nanoparticle mediated self-assembled gliP nanobiosensor for diagnosis of invasive aspergillosis. Int J Biol Macromol 110:449\u2013456. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.12.084","journal-title":"Int J Biol Macromol"},{"key":"3506_CR72","doi-asserted-by":"publisher","first-page":"128894","DOI":"10.1016\/j.snb.2020.128894","volume":"327","author":"JI Lee","year":"2020","unstructured":"Lee JI, Jang SC, Chung J, Choi WK, Hong C, Ahn GR, Kim SH, Lee BY, Chung WJ (2020) Colorimetric allergenic fungal spore detection using peptide-modified gold nanoparticles. Sens Actuators B Chem 327:128894. https:\/\/doi.org\/10.1016\/j.snb.2020.128894","journal-title":"Sens Actuators B Chem"},{"key":"3506_CR73","doi-asserted-by":"publisher","unstructured":"Abbas, H. S., Aly, A.E., Mohamed, H.M., Nabil, M.A., Mohamed El Sapagh, R.M., Abou Baker, DH (2022). Improvement of COVID-19 Diagnostic Tools: Nanobiosensors Challenges and Perspectives. In: Hameed, S., Rehman, S. (eds) Nanotechnology for Infectious Diseases. Springer, Singapore. https:\/\/doi.org\/10.1007\/978-981-16-9190-4_23.","DOI":"10.1007\/978-981-16-9190-4_23"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03506-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03506-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03506-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T06:03:51Z","timestamp":1704866631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03506-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03506-7","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"10"}}